Benzodiazepine binding sites in human pineal gland

The high affinity binding of [3H]flunitrazepam (FNZP) to crude membrane preparations was examined in human pineal glands. Scatchard analysis of the data at equilibrium revealed a single population of binding sites with dissociation constant = 2.36-2.53 nM and binding site concentration = 59-108 fmol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Lowenstein, P.R
Otros Autores: Rosenstein, R., Caputti, E., Cardinali, D.P
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1984
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 07161caa a22011297a 4500
001 PAPER-18272
003 AR-BaUEN
005 20230518204938.0
008 190411s1984 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0021738559 
024 7 |2 cas  |a 4 aminobutyric acid, 28805-76-7, 56-12-2; 4' chlorodiazepam, 14439-61-3; bicuculline, 485-49-4; clonazepam, 1622-61-3; diazepam, 439-14-5; flumazenil, 78755-81-4; flunitrazepam, 1622-62-4; Benzodiazepinones; Clonazepam, 1622-61-3; Diazepam, 439-14-5; Flumazenil, 78755-81-4; Flunitrazepam, 1622-62-4; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-A 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a EJPHA 
100 1 |a Lowenstein, P.R. 
245 1 0 |a Benzodiazepine binding sites in human pineal gland 
260 |c 1984 
270 1 0 |m Cardinali, D.P.; Centro de Estudios Farmacológicos y de Principios Naturales (CEFAPRIN), University of Buenos Aires, Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Bennett, Jr., Methods in binding studies (1978) Neurotransmitter Receptor Binding, p. 57. , H.I. Yamamura, S.J. Enna, M.J. Kuhar, Raven, New York 
504 |a Ebadi, Chan, Itoh, Hammad, Swanson, Govitrapong, The role of γ-aminobutyric acid in regulation of melatonin synthesis in bovine pineal gland (1984) Dynamics of Neurotransmitter Function, p. 177. , I. Hanin, Raven, New York 
504 |a Haefely, Bonetti, Burkard, Cumin, Laurent, Möhler, Pieri, Scherschlicht, Benzodiazepine antagonists (1983) The Benzodiazepines: From Molecular Biology to Clinical Practice, p. 134. , E. Costa, Raven, New York 
504 |a Haefely, Polc, Pieri, Schaffner, Laurent, Neuropharmacology of benzodiazepines: synaptic mechanisms and neural basis of action (1983) The Benzodiazepines: From Biology to Clinical Practice, p. 21. , E. Costa, Raven, New York 
504 |a Lowenstein, Cardinali, Characterization of flunitrazepam and beta-carboline high affinity binding in bovine pineal gland (1983) Neuroendocrinology, 37, p. 150 
504 |a Maggi, Satinover, Oberdorfer, Mann, Enna, Phylogenetic characteristics of muscimolactivated benzodiazepine receptor binding (1980) Brain Res. Bull., 5, p. 167 
504 |a Matthew, Parfitt, Sugden, Engelhardt, Zimmerman, Klein, Benzodiazepines: rat pinealocyte binding sites and augmentation of norepinephrine-stimulated N-acetyltransferase activity (1984) J. Pharmacol. Exp. Ther., 228, p. 434 
504 |a Müller, The benzodiazepine receptor, an update (1981) Pharmacology, 22, p. 153 
504 |a Olsen, GABA-benzodiazepine-barbiturate receptor interactions (1981) J. Neurochem., 37, p. 1 
504 |a Tallman, Mallorga, Thomas, Gallager, Benzodiazepine binding sites. Properties and modulation (1981) Neuropharmacology of Central Nervous System and Behavioral disorders, p. 9. , E. Costa, G. Di Chiara, G.L. Gessa, Raven, New York 
520 3 |a The high affinity binding of [3H]flunitrazepam (FNZP) to crude membrane preparations was examined in human pineal glands. Scatchard analysis of the data at equilibrium revealed a single population of binding sites with dissociation constant = 2.36-2.53 nM and binding site concentration = 59-108 fmol/mg protein. When various benzodiazepine (BZP) analogues were tested for their ability to inhibit [3H]FNZP binding the following Ki (nM) were found: clonazepam (0.13), RO 15-1788 (0.60), FNZP (2.14), diazepam (13.5), Ro 5-4864 (>10000). In both human pineal gland and cerebral cortex 10-100 μM γ-aminobutyric acid (GABA) increased BZP binding by about 30%, an effect inhibited by the GABA receptor blocker bicuculline. The stimulatory effect of GABA on [3H]FNZP binding in rat cerebral cortex (about 60%) decreased as a function of time elapsed postmortem at room temperature to reach values similar to those observed in human brains. These results suggest the existence of central type BZP receptors in the human pineal glands. © 1984.  |l eng 
536 |a Detalles de la financiación: Dipartimento della Protezione Civile, Presidenza del Consiglio dei Ministri 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: These studies were supported by grant No. 6638 from CONICET, Argentina, and by Hoechst AG, Werk Albert Wiesbaden, F.R.G. PRL holds a Postdoctoral Research Fellowship from CONICET and DPC is an Established Investigator, CONICET. 
593 |a Centro de Estudios Farmacológicos y de Principios Naturales (CEFAPRIN), University of Buenos Aires, Buenos Aires, Argentina 
593 |a Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina 
690 1 0 |a BENZODIAZEPINE RECEPTORS 
690 1 0 |a CEREBRAL CORTEX 
690 1 0 |a GABA 
690 1 0 |a HUMAN 
690 1 0 |a PINEAL GLAND 
690 1 0 |a 4 AMINOBUTYRIC ACID 
690 1 0 |a 4' CHLORODIAZEPAM 
690 1 0 |a BENZODIAZEPINE DERIVATIVE 
690 1 0 |a BENZODIAZEPINE RECEPTOR 
690 1 0 |a BICUCULLINE 
690 1 0 |a CLONAZEPAM 
690 1 0 |a DIAZEPAM 
690 1 0 |a FLUMAZENIL 
690 1 0 |a FLUNITRAZEPAM 
690 1 0 |a RADIOISOTOPE 
690 1 0 |a BRAIN CORTEX 
690 1 0 |a CENTRAL NERVOUS SYSTEM 
690 1 0 |a DRUG BINDING 
690 1 0 |a DRUG RECEPTOR BINDING 
690 1 0 |a FLUNITRAZEPAM H 3 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a NORMAL HUMAN 
690 1 0 |a PHARMACOKINETICS 
690 1 0 |a PINEAL BODY 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a ADOLESCENT 
690 1 0 |a ADULT 
690 1 0 |a AGED 
690 1 0 |a ANIMAL 
690 1 0 |a BENZODIAZEPINONES 
690 1 0 |a BINDING, COMPETITIVE 
690 1 0 |a CEREBRAL CORTEX 
690 1 0 |a CHILD 
690 1 0 |a CHILD, PRESCHOOL 
690 1 0 |a CLONAZEPAM 
690 1 0 |a DIAZEPAM 
690 1 0 |a FLUMAZENIL 
690 1 0 |a FLUNITRAZEPAM 
690 1 0 |a GAMMA-AMINOBUTYRIC ACID 
690 1 0 |a HUMAN 
690 1 0 |a IN VITRO 
690 1 0 |a INFANT 
690 1 0 |a KINETICS 
690 1 0 |a MALE 
690 1 0 |a MIDDLE AGE 
690 1 0 |a PINEAL GLAND 
690 1 0 |a RATS 
690 1 0 |a RATS, INBRED STRAINS 
690 1 0 |a RECEPTORS, GABA-A 
690 1 0 |a SUPPORT, NON-U.S. GOV'T 
653 0 0 |a ro 15 1788; ro 5 4864 
700 1 |a Rosenstein, R. 
700 1 |a Caputti, E. 
700 1 |a Cardinali, D.P. 
773 0 |d 1984  |g v. 106  |h pp. 399-403  |k n. 2  |p Eur. J. Pharmacol.  |x 00142999  |w (AR-BaUEN)CENRE-1772  |t European Journal of Pharmacology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021738559&doi=10.1016%2f0014-2999%2884%2990728-3&partnerID=40&md5=bf78f8a5859d9b98d80d255f6956d221  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/0014-2999(84)90728-3  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00142999_v106_n2_p399_Lowenstein  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00142999_v106_n2_p399_Lowenstein  |y Registro en la Biblioteca Digital 
961 |a paper_00142999_v106_n2_p399_Lowenstein  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 79225